These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6282965)

  • 1. Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP.
    Katz P; Roder JC; Zaytoun AM; Herberman RB; Fauci AS
    J Immunol; 1982 Jul; 129(1):297-302. PubMed ID: 6282965
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides.
    Katz P; Zaytoun AM; Fauci AS
    J Immunol; 1982 Jul; 129(1):287-96. PubMed ID: 6282964
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbachol and dibutyryl cyclic GMP on the vulnerability to ventricular fibrillation in rat isolated hearts.
    Daugherty A; Woodward B
    Br J Pharmacol; 1985 Jul; 85(3):621-7. PubMed ID: 2992667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses.
    Panush RS; Delafuente JC; Katz P; Johnson J
    Int J Vitam Nutr Res Suppl; 1982; 23():35-47. PubMed ID: 6288604
    [No Abstract]   [Full Text] [Related]  

  • 5. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins and cyclic nucleotides in the Chédiak-Higashi syndrome and experimental systemic lupus erythematosus.
    Zurier RB
    J Invest Dermatol; 1978 Jul; 71(1):36-9. PubMed ID: 210233
    [No Abstract]   [Full Text] [Related]  

  • 7. Membrane fluidity in human and mouse Chediak-Higashi leukocytes.
    Haak RA; Ingraham LM; Baehner RL; Boxer LA
    J Clin Invest; 1979 Jul; 64(1):138-44. PubMed ID: 221541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosette formation by human T and B lymphocytes in the presence of adrenergic and cholinergic drugs.
    Ferreira GG; Brascher HK; Javierre MQ; Sassine WA; Lima AO
    Experientia; 1976 Dec; 32(12):1594-6. PubMed ID: 191281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclic nucleotides on the longitudinal internal resistance in the rabbit sinus node.
    Tuganowski W; Bukowski M; Korczyńska I; Wasik K; Wójcik B
    Pol J Pharmacol Pharm; 1988; 40(1):5-9. PubMed ID: 2853336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.
    Katz P; Zaytoun AM; Fauci AS
    J Clin Invest; 1982 Jun; 69(6):1231-8. PubMed ID: 6177715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chediak-Higashi syndrome in an adult female].
    Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
    Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P; Zaytoun AM; Lee JH; Fauci AS
    J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphoid subpopulations in immunodeficiencies. Case reports].
    Diez RA; Sen L; Estevez ME; Giuntoli J
    Medicina (B Aires); 1981; 41 Suppl():147-54. PubMed ID: 7345339
    [No Abstract]   [Full Text] [Related]  

  • 16. Initiation of sporulation in Bacillus subtilis by cyclic-guanosine-3',5'-monophosphate under condition of catabolite repression.
    Majumdar S; Das SK; Basu S; Bose SK
    Indian J Biochem Biophys; 1985 Aug; 22(4):259-60. PubMed ID: 3009309
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-2-induced cytotoxicity of Chediak-Higashi lymphocytes.
    Holcombe RF
    Acta Haematol; 1992; 87(1-2):45-8. PubMed ID: 1533985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chediak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy.
    Harfi HA; Malik SA
    Ann Allergy; 1992 Aug; 69(2):147-50. PubMed ID: 1510287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chediak-Higashi syndrome: report of a case including electron microscopic findings (author's transl)].
    Ruiz-Esquide F; Reyes C; Vargas L; Strozzi L
    Rev Med Chil; 1979 Sep; 107(9):842-9. PubMed ID: 232296
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between the growth effects of a kidney epithelial cell growth inhibitor and extracellular concentrations of cyclic nucleotides.
    Fremuth F; Holley RW; Baldwin JH
    Neoplasma; 1982; 29(3):295-300. PubMed ID: 6290910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.